Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from China Wah Yan Healthcare ( (HK:0648) ).
SoftMedx Healthcare Limited has called its annual general meeting for 27 May 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and the directors’ and auditors’ reports for the year ended 31 December 2025. The board will also seek shareholder approval to set directors’ remuneration, reappoint Rongcheng (Hong Kong) CPA Limited as auditors, and renew mandates to issue up to 20% of its share capital and repurchase up to 10%, moves that preserve capital management flexibility and align with standard corporate governance practices for Hong Kong-listed issuers.
The proposed general mandate to issue new shares and the authority to repurchase existing shares would give the board additional tools to respond to funding needs and market conditions without convening separate meetings for each transaction. These resolutions, if passed, will remain effective until the next AGM or earlier revocation, and their approval would signal continued shareholder support for the company’s financial and capital structure strategies.
More about China Wah Yan Healthcare
SoftMedx Healthcare Limited is a Hong Kong-listed healthcare company, with its shares traded on the Stock Exchange of Hong Kong. The company operates under Hong Kong’s regulatory framework, maintaining audited consolidated financial statements and engaging external auditors to support transparency for investors and other stakeholders.
Average Trading Volume: 11,922,474
Technical Sentiment Signal: Sell
Current Market Cap: HK$664.1M
See more data about 0648 stock on TipRanks’ Stock Analysis page.